OBJECTIVE: To determine the utility of detecting a-synuclein (aSyn) in colonic mucosal biopsy tissue as a potential diagnostic biomarker for Parkinson disease (PD). METHODS: We used the paraffin-embedded tissue (PET) blot, which degrades physiologic nonaggregated aSyn using proteinase K and enhances antigen retrieval allowing sensitive and selective detection of remaining protein aggregates, to detect aSyn in colonic mucosal biopsies from 15 patients with early PD (,3 years), 7 patients with later PD (.5 years), and 11 individuals without PD. aSyn and serine 129–phosphorylated aSyn (Ser129p-aSyn) were assessed by PET blot and conventional immunohistochemistry. RESULTS: PET blot–resistant aggregated aSyn and Ser129p-aSyn was present in 12 of 15 individuals with early PD, 7 of 7 individuals with later PD, and 11 of 11 control subjects. The number of biopsies positive by PET blot relative to conventional immunohistochemistry was significantly lower in both PD groups compared with the control group for both aSyn and Ser129p-aSyn,whereas routine immunohistochemistry was positive more often in PD, but was positive in as many as 9 of 11 control individuals. CONCLUSION: Strong evidence of the presence of aggregated hyperphosphorylated aSyn in individuals with and without PD, using such a sensitive and specific method as the PET blot, suggests that colonic deposition of aSyn is not a useful diagnostic test for PD. The utility of detecting aSynin the colon as a biomarker in combination with other assessments remains to be determined.
OBJECTIVE: To determine the utility of detecting a-synuclein (aSyn) in colonic mucosal biopsy tissue as a potential diagnostic biomarker for Parkinson disease (PD). METHODS: We used the paraffin-embedded tissue (PET) blot, which degrades physiologic nonaggregated aSyn using proteinase K and enhances antigen retrieval allowing sensitive and selective detection of remaining protein aggregates, to detect aSyn in colonic mucosal biopsies from 15 patients with early PD (,3 years), 7 patients with later PD (.5 years), and 11 individuals without PD. aSyn and serine 129–phosphorylated aSyn (Ser129p-aSyn) were assessed by PET blot and conventional immunohistochemistry. RESULTS: PET blot–resistant aggregated aSyn and Ser129p-aSyn was present in 12 of 15 individuals with early PD, 7 of 7 individuals with later PD, and 11 of 11 control subjects. The number of biopsies positive by PET blot relative to conventional immunohistochemistry was significantly lower in both PD groups compared with the control group for both aSyn and Ser129p-aSyn,whereas routine immunohistochemistry was positive more often in PD, but was positive in as many as 9 of 11 control individuals. CONCLUSION: Strong evidence of the presence of aggregated hyperphosphorylated aSyn in individuals with and without PD, using such a sensitive and specific method as the PET blot, suggests that colonic deposition of aSyn is not a useful diagnostic test for PD. The utility of detecting aSynin the colon as a biomarker in combination with other assessments remains to be determined.
Authors: Heiko Braak; Kelly Del Tredici; Udo Rüb; Rob A I de Vos; Ernst N H Jansen Steur; Eva Braak Journal: Neurobiol Aging Date: 2003 Mar-Apr Impact factor: 4.673
Authors: Charles H Adler; Brittany N Dugger; Michael L Hinni; David G Lott; Erika Driver-Dunckley; Jose Hidalgo; Jonette Henry-Watson; Geidy Serrano; Lucia I Sue; Thomas Nagel; Amy Duffy; Holly A Shill; Haruhiko Akiyama; Douglas G Walker; Thomas G Beach Journal: Neurology Date: 2014-02-05 Impact factor: 9.910
Authors: W J Schulz-Schaeffer; S Tschöke; N Kranefuss; W Dröse; D Hause-Reitner; A Giese; M H Groschup; H A Kretzschmar Journal: Am J Pathol Date: 2000-01 Impact factor: 4.307
Authors: Philipp J Kahle; Manuela Neumann; Laurence Ozmen; Veronika Muller; Helmut Jacobsen; Will Spooren; Babette Fuss; Barbara Mallon; Wendy B Macklin; Hideo Fujiwara; Masato Hasegawa; Takeshi Iwatsubo; Hans A Kretzschmar; Christian Haass Journal: EMBO Rep Date: 2002-05-24 Impact factor: 8.807
Authors: Sidney Winawer; Robert Fletcher; Douglas Rex; John Bond; Randall Burt; Joseph Ferrucci; Theodore Ganiats; Theodore Levin; Steven Woolf; David Johnson; Lynne Kirk; Scott Litin; Clifford Simmang Journal: Gastroenterology Date: 2003-02 Impact factor: 22.682
Authors: Thomas G Beach; Anne-Gaëlle Corbillé; Franck Letournel; Jeffrey H Kordower; Thomas Kremer; David G Munoz; Anthony Intorcia; Joseph Hentz; Charles H Adler; Lucia I Sue; Jessica Walker; Geidy Serrano; Pascal Derkinderen Journal: J Parkinsons Dis Date: 2016-10-19 Impact factor: 5.568
Authors: F Giancola; F Torresan; R Repossi; F Bianco; R Latorre; A Ioannou; M Guarino; U Volta; P Clavenzani; M Mazzoni; R Chiocchetti; F Bazzoli; R A Travagli; C Sternini; R De Giorgio Journal: Neurogastroenterol Motil Date: 2016-11-27 Impact factor: 3.598
Authors: Jared T Hinkle; Kate Perepezko; Kelly A Mills; Zoltan Mari; Ankur Butala; Ted M Dawson; Alexander Pantelyat; Liana S Rosenthal; Gregory M Pontone Journal: Parkinsonism Relat Disord Date: 2018-08-22 Impact factor: 4.891